Rx Spending Continues To Lag Overall Health Growth; New Drugs Have Positive Impact in 2011 Data
This article was originally published in RPM Report
Prescription drug spending modestly increased in 2011 but continues to lag historically slow rates of overall health spending growth. But it could have been worse: government actuaries cite spending on new brands as driving what growth there is.
You may also be interested in...
Drug Spending Expected To Rise By $200 Bil. In 2022 Compared To Pre-ACA Levels
Implementation of the Affordable Care Act in 2014 will help significantly increase growth for pharma. The increase won’t be as big as it might have been, thanks to the Supreme Court ruling allowing states to opt out of Medicaid expansion, but it should still be a significant acceleration.
Part D’s Standard Deductible, Copays To Drop In 2014
With dropping drug expenses in Part D, CMS’ annual call letter for Part D drug plans proposes reducing beneficiary expenses for the standard plan in 2014, the first drop since the program began.
Pharma Projected to Have ACA to Thank for Growth - Assuming it Remains As-Is
The Centers for Medicare and Medicaid’s Office of the Actuary projects that aggregate health care spending will grow modestly - then spike in 2014. That’s due to coverage expansions in the Affordable Care Act, and pharma stands to get among the biggest gains. The June report release means industry would have at least a couple weeks to enjoy the projections before they potentially no longer apply.